The Jehovah’s Witnesses have partly eased their long-standing prohibition on the medical use of donated blood, allowing ...
The U.S. is working on rules for investing in China that would likely preserve pharma's ability to strike most licensing ...
We’re very actively hiring,” Karim Mikhail, director of FDA’s Center for Biologics Evaluation and Research, told drug ...
Kennedy Jr. named eight new members to the U.S. Preventive Services Task Force, an influential panel of experts who assess ...
Over the past 25 years, there’s been a dramatic change in how we understand children who don’t “listen,” writes behavioral ...
Before passing their tax-cut law, they added in $50 billion over the next five years. This rural health fund was intended to ...
As part of broad drug pricing deals with the Trump administration, more than two dozen pharma companies agreed to sell drugs to state Medicaid programs at prices available in peer countries under ...
The FDA approved a new gene therapy for Sanfilippo syndrome type A, an ultra-rare disease sometimes known as childhood ...
A breast cancer drug from AstraZeneca will now be available in England after a pricing deal was reached, in part a result of ...
The lawsuit seeks to halt the process of searching grant applications for specific terms to determine if they should be ...
An FDA pilot program to speed up drug development, Democrats plan health care probes after midterms, and more biotech news ...
Cautious optimism in the Ebola outbreak, FDA still stymied by DOGE cuts, and other health updates from the Morning Rounds ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results